Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: G-9553-2015
Scopus Author ID: 7201401199

Activities

Collapse all

Employment (2)

University of Melbourne: Melbourne, VIC, AU

2011-09-01 to present | Head of Department (Physiology)
Employment
Source: Self-asserted source
Gordon Lynch

University of Melbourne: Melbourne, VIC, AU

2008-06-01 to present | Professor (Physiology)
Employment
Source: Self-asserted source
Gordon Lynch

Education and qualifications (3)

University of Michigan: Ann Arbor, MI, US

1995-01-15 to 1997-05-01 | Postdoctoral (Physiology/Gerontology)
Education
Source: Self-asserted source
Gordon Lynch

University of Melbourne: Melbourne, VIC, AU

1988-02-01 to 1992-08-01 | Ph.D. (Physiology)
Education
Source: Self-asserted source
Gordon Lynch

La Trobe University: Bundoora, VIC, AU

1987-02-01 to 1988-01-01 | BSc (Honours) (Zoology)
Education
Source: Self-asserted source
Gordon Lynch

Funding (28)

Heat shock protein therapy for muscle wasting

2014-01-01 to 2018-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1065456
GRANT_NUMBER: 1065456
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Maintaining muscle size and function

2013-01-01 to 2016-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1046501
GRANT_NUMBER: 1046501
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Novel therapies to treat muscle wasting in cancer

2013-01-01 to 2016-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1041865
GRANT_NUMBER: 1041865
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

(Multi-scale imaging and characterisation facility for biological structure and function)

2013-01-01 to 2013-12-31 | Grant
Australian Research Council (Canberra, AU)
GRANT_NUMBER: LE130100114
GRANT_NUMBER: LE130100114
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

(Role of suppressor of cytokine signalling proteins (SOCS3) in defective muscle repair and ageing)

2012-01-01 to 2014-12-31 | Grant
Australian Research Council (Canberra, AU)
GRANT_NUMBER: DP120101494
GRANT_NUMBER: DP120101494
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Novel Muscle Therapeutics Through Selective Beta-Adrenoceptor Signalling

2012-01-01 to 2014-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1026231
GRANT_NUMBER: 1026231
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

The role of heat shock protein in muscular dystrophy

2011-01-01 to 2013-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1009114
GRANT_NUMBER: 1009114
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

In vitro evaluation of compound efficacy for skeletal muscle conditions.

2011-01 to 2011-12 | Contract
BioIberica (Barcelona, ES)
Source: Self-asserted source
Gordon Lynch

Novel anti-fibrotic therapies for muscular dystrophy and muscle injuries.

2011-01 to 2011-12 | Contract
University of Melbourne (VIC, VIC, AU)
Source: Self-asserted source
Gordon Lynch

Modulating IGF:IGFBP signaling to improve muscle function in muscular dystrophy.

2010-07 to 2013-06 | Grant
Muscular Dystrophy Association (AZ, AZ, US)
GRANT_NUMBER:

68158
Source: Self-asserted source
Gordon Lynch

Optimising the therapeutic potential of formoterol for muscular dystrophy and other muscle wasting disorders.

2010-01 to 2012-01 | Grant
Association Francaise contre les Myopathies (Paris, FR)
GRANT_NUMBER:

14976
Source: Self-asserted source
Gordon Lynch

Developing safe and effective therapies to combat frailty and muscle weakness in the elderly

2010-01 to 2010-12 | Grant
Rebecca L. Cooper Medical Research Foundation (NSW, NSW, AU)
Source: Self-asserted source
Gordon Lynch

Enhancing growth signalling pathways to improve muscle growth and development in muscular dystrophy

2009-01-01 to 2011-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 566820
GRANT_NUMBER: 566820
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

The role of Notch signalling in muscular dystrophy

2009-01-01 to 2011-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 566818
GRANT_NUMBER: 566818
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Characterization of cardiovascular parameters in rats during pharmacological interventions.

2009-01 to 2010-12 | Contract
Merck (NJ, NJ, US)
Source: Self-asserted source
Gordon Lynch

Improving muscle regeneration in muscular dystrophy

2008-01-01 to 2010-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 509313
GRANT_NUMBER: 509313
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Preclinical evaluation of muscular dystrophies as target diseases for RO5046013

2008-01 to 2010-12 | Contract
Hoffman-La Roche (Basel, CH)
Source: Self-asserted source
Gordon Lynch

Therapeutic potential of a new generation β-agonist, formoterol, to attenuate muscle wasting, enhance muscle regeneration and improve function in muscle diseases

2008-01 to 2009-12 | Grant
Association Francaise contre les Myopathies (Paris, FR)
Source: Self-asserted source
Gordon Lynch

Investigating the potential for erectile dysfunction drugs to enhance the repair of injured skeletal muscles in the elderly.

2008-01 to 2008-12 | Grant
Rebecca L. Cooper Medical Research Foundation (NSW, NSW, AU)
Source: Self-asserted source
Gordon Lynch

Skeletal muscle modifications with exercise and ergogenic supplements.

2008-01 to 2008-12 | Grant
Defence Science and Technology Organisation (ACT, ACT, AU)
Source: Self-asserted source
Gordon Lynch

Smad7 over-expression: a novel therapy for attenuating ageing-related muscle weakness.

2008-01 to 2008-12 | Grant
Australian Association of Gerontology (Melbourne, AU)
Source: Self-asserted source
Gordon Lynch

Improving muscle function after injury

2007-01-01 to 2009-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 454561
GRANT_NUMBER: 454561
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Growth factor therapy for improving muscle function in muscular dystrophy

2006-01 to 2008-01 | Grant
Muscular Dystrophy Association (AZ, AZ, US)
Source: Self-asserted source
Gordon Lynch

Improving muscle regeneration in muscular dystrophy

2005-01-01 to 2007-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 350439
GRANT_NUMBER: 350439
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Efficacy and safety of novel approaches to attenuate skeletal muscle wasting and weakness

2005-01 to 2007-12 | Contract
Pfizer (NY, NY, US)
Source: Self-asserted source
Gordon Lynch

Repair of the dystrophin gene in the mdx mouse.

2001-01-01 to 2003-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 145712
GRANT_NUMBER: 145712
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

CALCIUM AND MUSCLE REGENERATION

1999-01-01 to 2001-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 990801
GRANT_NUMBER: 990801
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Mechanisms of contraction-induced injury in dystrophic skeletal muscle

1995-01-01 to 1998-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 957334
GRANT_NUMBER: 957334
Source: Self-asserted source
Gordon Lynch via DimensionsWizard

Peer review (4 reviews for 4 publications/grants)

Review activity for Disease models & mechanisms (1)
Review activity for eLife (1)
Review activity for Nature communications (1)
Review activity for Nature reviews. (1)
How many people are using ORCID?